An in depth analysis of clinical and virological outcomes of 2 strategies for the antiretroviral salvage of first-line regimen virological failure for HIV-1 infection tested in an Australian-led randomised, international, multi-centre clinical trial

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The recently completed Australian-led SECOND-LINE trial is the first high quality study to provide reliable evidence for policy recommendations for the composition of anti-HIV drug cocktails after standard initial treatment has failed. This award will support the researcher in further refining our understanding of how to manage second-line therapy including proposals to test the use of low-cost technologies for application in resource-limited settings where the majority of people with HIV live.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Career Development Fellowships

Funding Amount: $421,747.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Infectious Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

antiretroviral therapy | body composition | bone mineral density | clinical research | collaboration | efficacy | evidence-based clinical practice | human immunodeficiency virus (HIV) | modelling | safety